Virus complement evasion strategies

Journal of General Virology

Volumn 84, Issue 1, 2003, Pages 1-15

  Favoreal, Herman W ^a   Van de Walle, Gerlinde R ^a   Nauwynck, Hans J ^a   Pensaert, Maurice B ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MANNAN BINDING LECTIN; VIRUS VACCINE;

ANTIGEN RECOGNITION; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT SYSTEM; CORONAVIRUS; HERPES VIRUS; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNE SYSTEM; MOLECULAR EVOLUTION; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; RETROVIRUS; REVIEW; TOGAVIRUS; VACCINATION; VIRION; VIRUS INFECTION; VIRUS RESISTANCE;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY; MICE; VIRUS DISEASES; VIRUSES;

CORONAVIRUS; HERPESVIRIDAE; POXVIRIDAE; TOGAVIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 0037232092     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18709-0     Document Type: Review

References (112)

1. Adler, R., Glorioso, J. C., Cossman, J. & Levine, M. (1978). Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis. Infect Immun 21, 442-447.
2. Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Osorio, F. A., Balinsky, C., Kutish, G. F. & Rock, D. L. (2002). The genome of swinepox virus. J Virol 76, 783-790.
3. Albrecht J. C. & Fleckenstein, B. (1992). New member of the multigene family of complement control proteins in herpesvirus saimiri. J Virol 66, 3937-3940.
4. Albrecht, J. C., Nicolas, J., Biller, D. & 7 other authors (1992a). Primary structure of the herpesvirus saimiri genome. J Virol 66, 5047-5058.
5. Albrecht, J. C., Nicolas, J., Cameron, K. R., Newman, C., Fleckenstein, B. & Honess, R. W. (1992b). Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology 190, 527-530.
6. Appleyard, G., Hapel, A. J. & Boulter, E. A. (1971). An antigenic difference between intracellular and extracellular rabbitpox virus. J Gen Virol 13, 9-17.
7. Atalay, R., Zimmermann, A., Wagner, M., Borst E., Benz, C., Messerle, M. & Hengel, H. (2002). Identification and expression of human cytomegalovirus transcription units coding for two distinct Fc gamma receptor homologs. J Virol 76, 8596-8608.
8. Barrett, J. W., Cao, J. X., Hota-Michell, S. & McFadden, G. (2001). Immunomodulatory proteins of myxoma virus. Semin Immunol 13, 73-84.
9. Bavari, S., Bosio, C. M., Wiegand, E. & 7 other authors (2002). Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195, 593-602.
10. Benichou, G. & Voisin, G. A. (1987). Antibody bipolar bridging: isotype-dependent signals given to guinea pig alveolar macrophages by anti-MHC alloantibodies. Cell Immunol 106, 304-317.
11. Bergelson, J. M., Chan, M., Solomon, K R., St John, N. F., Lin, H. & Finberg, R. W. (1994). Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci U S A 91, 6245-6249.
12. Betts, R. F. & Schmidt S. G. (1981). Cytolytic IgM antibody to cytomegalovirus in primary cytomegalovirus infection in humans. J Infect Dis 143, 821-826.
13. Cooper, N. R., Jensen, F. C., Welsh, R. M., Jr & Oldstone, M. B. (1974). Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med 144, 970-984.
14. Crnkovic-Mertens, I., Messerle, M., Milotic, I., Szepan, U., Kucic, N., Krmpotic, A., Jonjic, S. & Koszinowski, U. H. (1998). Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J Virol 72, 1377-1382.
15. Dorig, R. E., Marcil, A., Chopra, A. & Richardson, C. D. (1993). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305.
16. Dowler, K. W. & Veltri, R. W. (1984). In vitro neutralization of HSV-2: inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR). J Med Virol 13, 251-259.
17. Dubin, G., Frank, I. & Friedman, H. M. (1990). Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes. J Virol 64, 2725-2731.
18. Dubin, G., Socolof, E., Frank, I. & Friedman, H. M. (1991). Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol 65, 7046-7050.
19. Dubin, G., Basu, S., Mallory, D. L. P., Basu, M., Tal-Singer, R. & Friedman, H. M. (1994). Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin aggregates. J Virol 68, 2478-2486.
20. Ebenbichler, C. F., Thielens, N. M., Vornhagen, R., Marschang, P., Arlaud, G. J. & Dierich, M. P. (1991). Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J Exp Med 174, 1417-1424.
21. Engelstad, M., Howard, S. T. & Smith, G. L. (1992). A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188, 801-810.
22. Favoreel, H. W., Nauwynck, H. J., Van Oostveldt, P., Mettenleiter, T. C. & Pensaert, M. B. (1997). Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells. J Virol 71, 8254-8261.
23. Favoreel, H. W., Nauwynck, H. J. & Pensaert, M. B. (1999a). Role of the cytoplasmic tail of gE in antibody-induced redistribution of viral glycoproteins expressed on pseudorabies virus-infected cells. Virology 259, 141-147.
24. Favoreel, H. W., Nauwynck, H. J., Halewyck, H. M., Van Oostveldt, P., Mettenleiter, T. C. & Pensaert, M. B. (1999b). Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes. J Gen Virol 80, 1283-1291.
25. Favoreel, H. W., Van Minnebruggen, G., Nauwynck, H. J., Enquist, L. W. & Pensaert, M. B. (2002). A tyrosine-based motif in the cytoplasmic tail of pseudorabies virus glycoprotein B is important for both antibody-induced internalization of viral glycoproteins and efficient cell-to-cell spread. J Virol 76, 6845-6851.
26. Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A. & Fearon, D. T. (1984). Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A 81, 4510-4514.
27. Fodor, W. L., Rollins, S. A., Blanco-Caron, S., Rother, R. P., Guilmette, E. R., Burton, W. V., Albrecht J. C., Fleckenstein, B. & Squinto, S. P. (1995). The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J Virol 69, 3889-3892.
28. Frank I. & Friedman, H. M. (1989). A novel function of the herpes simplex virus type I Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol 63, 4479-4488.
29. Friedman, H. M., Cohen, G. H., Eisenberg, R. J., Seidel, C. A. & Cines, D. B. (1984). Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 309, 633-634.
30. Fries, L. F., Friedman, H. M., Cohen, G. H., Eisenberg, R. J., Hammer, C. H. & Frank M. M. (1986). Glycoprotein gC of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol 137, 1636-1641.
31. Hakozaki, Y., Yoshiba, M., Sekiyama, K. & 8 other authors (2002). Mannose-binding lectin and the prognosis of fulminant hepatic failure caused by HBV infection. Liver 22, 29-34.
32. Hannan, L. A. & Edidin, M. (1996). Traffic, polarity, and detergent solubility of a glycosylphosphatidylinositol-anchored protein after LDL-deprivation of MDCK cells. J Cell Biol 133, 1265-1276.
33. Harris, C. L., Spiller, O. B. & Morgan, B. P. (2000). Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities. Immunology 100, 462-470.
34. Haurum, J. S., Thiel, S., Jones, I. M., Fischer, P. B., Laursen, S. B. & Jensenius, J. C. (1993). Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7, 1307-1313.
35. Herold, B. C., WuDunn, D., Soltys, N. & Spear, P. G. (1991). Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to the cells and in infectivity. J Virol 65, 1090-1098.
36. Hirsch, R. L., Griffin, D. E. & Winkelstein, J. A. (1981). Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance. J Immunol 127, 1740-1743.
37. Hirsch, R. L., Griffin, D. E. & Winkelstein, J. A. (1983). Natural immunity to Sindbis virus is influenced by host tissue sialic acid content. Proc Natl Acad Sci U S A 80, 548-550.
38. Howard, J., Justus, D. E., Totmenin, A. V., Schelkunov, S. & Kotwal, G. J. (1998). Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat. J Leukoc Biol 64, 68-71.
39. Huemer, H. P., Larcher, C. & Coe, N. E. (1992). Pseudorabies virus glycoprotein III derived from virions and infected cells binds to the third component of complement. Virus Res 23, 271-280.
40. Huemer, H. P., Larcher, C., van Drunen Littel-van den Hurk, S. & Babiuk, L. A. (1993). Species selective interaction of Alphaherpesvirinae with the 'unspecific' immune system of the host. Arch Virol 130, 353-364.
41. Huemer, H. P., Nowotny, N., Crabb, B. S., Meyer, H. & Hubert, P. H. (1995). gp13 (EHV-gC): A complement receptor induced by equine herpesviruses. Virus Res 37, 113-126.
42. Hung, S. L., Srinivasan, S., Friedman, H. M., Eisenberg, R. J. & Cohen, G. H. (1992). Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J Virol 66, 4013-4027.
43. Hung, S. L., Peng, C., Kostavasili, I., Friedman, H. M., Lambris, J. D., Eisenberg, R. J. & Cohen, G. H. (1994). The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 203, 299-312.
44. Ikeda, F., Haraguchi, Y., Jinno, A., Iino, Y., Morishita, Y., Shiraki, H. & Hoshino, H. (1998). Human complement component C1q inhibits the infectivity of cell-free HTLV-I. J Immunol 161, 5712-5719.
45. Isaacs, S. N., Kotwal, G. J. & Moss, B. (1992). Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci U S A 89, 628-632.
46. Ishak, R., Andiman, W. A. & Tucker, G. (1984). Absence of IgG Fc receptors on varicella-zoster virus-infected cells. J Med Virol 13, 261-267.
47. Janeway, C. A., Travers, P., Walport, M. & Shlomchik, M. (2001). Immunobiology - The Immune System in Health and Disease. New York: Garland Publishing.
48. Johnson, D. C. & Feenstra, V. (1987). Identification of a novel herpesvirus simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J Virol 61, 2208-2216.
49. Johnson, D. C., Frame, M. C., Ligas, M. W., Cross, A. M. & Stow, N. D. (1988). Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 62, 1347-1354.
50. Kapadia, S. B., Molina, H.,van Berckel, V., Speck, S. H., & Virgin, H. W., IV (1999). Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol 73, 7658-7670.
51. Kase, T., Suzuki, Y., Kawai, T. & 7 other authors (1999). Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97, 385-392.
52. Kostavasili, J., Sahu, A., Friedman, H. M., Eisenberg, R. J., Cohen, G. H. & Lambris, J. D. (1997). Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J Immunol 158, 1763-1771.
53. Kotwal, G. J., Isaacs, S. N., McKenzie, R., Frank, M. M. & Moss, B. (1990). Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250, 827-830.
54. Kotwal, G. J., Miller, C. G. & Justus, D. E. (1998). The inflammation protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation. Mol Cell Biochem 185, 39-46.
55. Kubota, Y., Gaither, T. A., Cason, J., Oshea, J. J. & Lawley, T. J. (1987). Characterization of the C3 receptor induced by herpes simplex virus type 1 infection in human epidermal, endothelial, and A431 cells. J Immunol 138, 1137-1142.
56. Lee, H. J., Essani, K. & Smith, G. L. (2001). The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology 281, 170-192.
57. Lilley, B. N., Ploegh, H. L. & Tirabassi, R. S. (2001). Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol 75, 11218-11221.
58. Litwin, V. & Grose, C. (1992). Herpesviral Fc receptors and their relationship to the human Fc receptors. Immunol Res 11, 226-238.
59. Litwin, V., Sandor, M. & Grose, C. (1990). Cell surface expression of the varicella-zoster glycoproteins and Fc receptor. Virology 178, 263-272.
60. Litwin, V., Jackson, W. & Grose, C. (1992). Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol 66, 3643-3651.
61. Lubinski, J. M., Wang, L., Soulika, A. M. & 7 other authors (1998). Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J Virol 72, 8257-8263.
62. Lubinski, J. M., Wang, L., Mastellos, D., Sahu, A., Lambris, J. D. & Friedman, H. M. (1999). In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J Exp Med 190, 1637-1646.
63. Lubinski, J. M., Jiang, M., Hook, L. & 7 other authors (2002). Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J Virol 76, 9232-9241.
64. MacCormac, L. P. & Grundy, J. P. (1996). Human cytomegalovirus induces an Fc gamma receptor (Fc gammaR) in endothelial cells and fibroblasts that is distinct from the human cellular Fc gammaRs. J Infect Dis 174, 1151-1161.
65. Mackowiak, P. A. & Marling-Cason, M. (1987). Immunoreactivity of cytomegalovirus-induced Fc receptors. Microbiol Immunol 31, 427-434.
66. McKenzie, R., Kotwal, G. J., Moss, B., Hammer, C. H. & Frank, M. M. (1992). Regulation of complement activity by vaccinia virus complement-control protein. J Infect Dis 166, 1245-1250.
67. Maeda, K., Hayashi, S., Tanioka, Y., Matsumoto, Y. & Otsuka, H. (2002). Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC). Virus Res 84, 79-87.
68. Meri, S. & Pangburn, M. K. (1990). Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci U S A 87, 3982-3986.
69. Mettenleiter, T. C., Zsak, L., Zuckermann, F., Sugg, N., Kern, H. & Ben-Porat, T. (1990). Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus. J Virol 64, 278-286.
70. Middeldorp, J. M., Jongsma, J. & The, T. H. (1986). Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement. J Infect Dis 153, 48-55.
71. Mold, C., Bradt B. M., Nemerow, G. R. & Cooper, N. R. (1988). Epstein-Barr virus regulates activation and processing of the third component of complement. J Exp Med 168, 949-969.
72. Nagashunmugam, T., Lubinski, J., Wang, L., Goldstein, L. T., Weeks, B. J., Sundaresan, P., Kang, E. H., Dubin, G. & Friedman, H. M. (1998). In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol 72, 5351-5359.
73. Naniche, D., Varlor-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C. & Gerlier, D. (1993). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67, 6025-6032.
74. Nauwynck, H. J. & Pensaert, M. B. (1992). Abortion induced by cell-associated pseudorabies virus in vaccinated sows. Am J Vet Res 53, 489-493.
75. Nguyen, D. H. & Hildreth, J. E. (2000). Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 74, 3264-3272.
76. Ogata, M. & Shigeta, S. (1979). Appearance of immunoglobulin G Fc receptor in cultured human cells infected with varicella-zoster virus. Infect Immun 26, 770-774.
77. Oleszak, E. L. (1994). Molecular mimicry between Fc receptors and viral antigens. Arch Immunol Ther Exp 42, 83-88.
78. Oleszak, E. L., Perlman, S., Parr, R., Collisson, E. W. & Leibowitz, J. L. (1993). Molecular mimicry between S peplomer proteins of coronaviruses (MHV, BCV, TGEV and IBV) and Fc receptor. Adv Exp Med Biol 342, 183-188.
79. Oleszak, E. L., Kuzmak, J., Hogue, B., Parr, R., Collisson, E. W., Rodkey, L. S. & Leibowitz, J. L. (1995). Molecular mimicry between Fc receptor and S peplomer protein of mouse hepatitis virus, bovine corona virus, and transmissible gastroenteritis virus. Hybridoma 14, 1-8.
80. Ono, A. & Freed, E. O. (2001). Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A 98, 13925-13930.
81. Pangburn, M. K. (1986). Immunobiology of the Complement System, pp. 45-62. Edited by G. D. Ross. New York: Academic Press.
82. Para, M. F., Baucke, R. B. & Spear, P. G. (1982). Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced Fc-binding receptors. J Virol 41, 129-136.
83. Perez de la Lastra, J. M., Harris, C. L., Hinchliffe, S. J., Holt D. S., Rushmere, N. K. & Morgan, B. P. (2000). Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats. J Immunol 165, 2563-2573.
84. Rahman, A. A., Teschner, M., Sethi, K. K. & Brandis, H. (1976). Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus. J Immunol 117, 253-258.
85. Reading, P. C., Morey, L. S., Crouch, E. C. & Anders, E. M. (1997). Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71, 8204-8212.
86. Rosengard, A. M., Liu, Y., Nie, Z. & Jimenez, R. (2002). Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc Natl Acad Sci U S A 99, 8808-8813.
87. Rother, R. P., Rollins, S. A., Fodor, W. F., Albrecht, J. C., Setter, E., Fleckenstein, B. & Squinto, S. P. (1994). Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol 68, 730-737.
88. Rushmere, N. K., Tomlinson, S. & Morgan, B. P. (1997). Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function. Immunology 90, 640-646.
89. Rux, A. H., Lou, H., Lambris, J. D., Friedman, H. M., Eisenberg, R. J. & Cohen, G. H. (2002). Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulphate, and complement component C3b. Virology 294, 324-332.
90. Saifuddin, M., Parker, C. J., Peeples, M. E., Gorny, M. K., Zolla-Opazner, S., Ghassemi, M., Rooney, I. A., Atkinson, J. P. & Spear, G. T. (1995). Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 182, 501-509.
91. Saifuddin, M., Hedayati, T., Atkinson, J. P., Holgiun, M. H., Parker, C. J. & Spear, G. T. (1997). Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD64 at levels that protect from complement-mediated destruction. J Gen Virol 78, 1907-1911.
92. Sasaki, K., Tsutsumi, A., Wakamiya, N., Ohtani, K., Suzuki, Y., Watanabe, Y., Nakayama, N. & Koike, T. (2000). Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand J Gastroenterol 35, 960-965.
93. Scheiffele, P., Rietveld, A., Wilk, T. & Simons, K. (1999). Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem 274, 2038-2044.
94. Schmelz, M., Sodeik, B., Ericsson, M., Wolffe, E. J., Shida, H., Hiller, G. & Griffiths, G. (1994). Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol 68, 130-147.
95. Schreurs, C., Mettenleiter, T. C., Zuckermann, F., Sugg, N. & Ben-Porat, T. (1988). Glycoprotein gIII of pseudorabies virus is multifunctional. J Virol 62, 2251-2257.
96. Seidel-Dugan, C., Ponce de Leon, M., Friedman, H. M., Eisenberg, R. J. & Cohen, G. H. (1990). Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C. J Virol 64, 1897-1906.
97. Smiley, M. L., Hoxie, J. A. & Friedman, H. M. (1985). Herpes simplex virus type 1 infection of endothelial, epithelial and fibroblast cells induces a receptor for C3b. J Immunol 134, 2673-2678.
98. Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M., Payne, G. H. & Saifuddin, M. (1995). Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type 1 (HTLV-1) and human cytomegalovirus (HCMV). J Immunol 155, 4376-4381.
99. Spiller, O. B. & Morgan, B. P. (1998). Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblasts. J Infect Dis 178, 1597-1603.
100. Spiller, O. B., Morgan, B. P., Tufaro, F. & Devine, D. V. (1996). Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur J Immunol 26, 1532-1538.
101. Stannard, L. M. & Hardie, D. R. (1991). An Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus. J Virol 65, 3411-3415.
102. Stoiber, H., Kacani, L., Speth, C., Würzner, R. & Dierich, M. P. (2001). The supportive role of complement in HIV pathogenesis. Immunol Rev 180, 168-176.
103. Takahashi-Nishimaki, F., Funahashi, S., Miki, K., Hashizume, S. & Sugimoto, M. (1991). Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins. Virology 181, 158-164.
104. Thäle, R., Lucin, P., Schneider, K., Eggers, M. & Koszinowski, U. H. (1994). Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol 68, 7757-7765.
105. Tooze, J., Hollinshead, M., Reis, B., Radsak, K. & Kern, H. (1993). Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur J Cell Biol 60, 163-178.
106. Van den Berg, C. W. & Morgan, B. P. (1994). Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted. J Immunol 152, 4095-4101.
107. Vanderplasschen, A., Mathew, E., Hollinshead, M., Sim, R. B. & Smith, G. L. (1998). Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A 95, 7544-7549.
108. Van de Walle, G. R., Favoreel, H. W., Nauwynck, H. J., Van Oostveldt, P. & Pensaert, M. B. (2001). Involvement of cellular cytoskeleton components in antibody-induced internalization of viral glycoproteins in pseudorabies virus-infected monocytes. Virology 288, 129-138.
109. Vincent S., Gerlier, D. & Manie, S. N. (2000). Measles virus assembly within membrane rafts. J Virol 74, 9911-9915.
110. Virgin, H. W., IV, Latreille, P., Wamsley, P., Hallsworth, K., Weck, K. E., Dal Canto, A. J. & Speck, S. H. (1997). Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71, 5894-5904.
111. Watkins, J. F. (1964). Adsorption of sensitized sheep erythrocytes to HeLa cells infected with herpes simplex virus. Nature 202, 1364-1365.
112. Westmoreland, D. & Watkins, J. F. (1974). The IgG receptor induced by herpes simplex virus: studies using radioiodinated IgG. J Gen Virol 24, 167-178.